Skip to content

Epidemiology of Depression, Anxiety, and Cognitive Impairment

Epidemiology of Depression, Anxiety, and Cognitive Impairment Among Emergency Department Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00717041
Enrollment
1206
Registered
2008-07-16
Start date
2008-05-31
Completion date
2009-02-28
Last updated
2015-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Cognitive Impairment, Depression

Keywords

Depression, Anxiety, Cognitive Impairment, Emergency medicine, prehospital care

Brief summary

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise. The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.

Detailed description

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise. The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. This study aims to: 1. Compare the prevalence of depression and cognitive impairment among patients who arrive at the ED by EMS, as compared to those arriving via other means. 2. Evaluate the reliability of screening patients for depression and cognitive impairment during an acute illness and after the illness. 3. To evaluate correlates of depression, anxiety and suicidal ideation. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.

Interventions

None listed

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Rochester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 and older * Arrival at ED

Exclusion criteria

* Institutionalized

Design outcomes

Primary

MeasureTime frameDescription
Participants With Depression by Patient Health Questionnaire - 92 hoursNumber of participants with depression as measured by the Patient Health Questionnaire - 9, with a score of greater than or equal to 10.
Participants With Cognitive Impairment by Six Item Screener2 hoursNumber of participants with cogintiive impairment as measured by the Six Item Screener, with greater than 2 questions incorrect
Participants With Anxiety by Generalized Anxiety Disorder - 72 hoursParticipants with anxiety as measured by the Generalized Anxiety Disorder - 7, with a score greater than or equal to 10.

Secondary

MeasureTime frameDescription
Depression and Cognitive Impairment at 2 Weeks2 weeksFor the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment.

Countries

United States

Participant flow

Participants by arm

ArmCount
Presenting to the ED
Patients who present to the ED
1,206
Total1,206

Baseline characteristics

CharacteristicPresenting to the ED
Age, Continuous71 years
Anxiety (>=10 on GAD7)119 participants
Cognitive Impairment (>2 on SIS)106 participants
Depression (>=10 on PHQ9)177 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1184 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
13 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
178 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
28 Participants
Race (NIH/OMB)
White
1000 Participants
Region of Enrollment
United States
1206 participants
Sex: Female, Male
Female
634 Participants
Sex: Female, Male
Male
572 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 1,206
serious
Total, serious adverse events
0 / 1,206

Outcome results

Primary

Participants With Anxiety by Generalized Anxiety Disorder - 7

Participants with anxiety as measured by the Generalized Anxiety Disorder - 7, with a score greater than or equal to 10.

Time frame: 2 hours

ArmMeasureValue (NUMBER)
Presenting to the EDParticipants With Anxiety by Generalized Anxiety Disorder - 7119 participants
Primary

Participants With Cognitive Impairment by Six Item Screener

Number of participants with cogintiive impairment as measured by the Six Item Screener, with greater than 2 questions incorrect

Time frame: 2 hours

ArmMeasureValue (NUMBER)
Presenting to the EDParticipants With Cognitive Impairment by Six Item Screener106 participants
Primary

Participants With Depression by Patient Health Questionnaire - 9

Number of participants with depression as measured by the Patient Health Questionnaire - 9, with a score of greater than or equal to 10.

Time frame: 2 hours

ArmMeasureValue (NUMBER)
Presenting to the EDParticipants With Depression by Patient Health Questionnaire - 9177 participants
Secondary

Depression and Cognitive Impairment at 2 Weeks

For the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment.

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
Presenting to the EDDepression and Cognitive Impairment at 2 Weeks27 participants
Cognitively Impaired in the EDDepression and Cognitive Impairment at 2 Weeks5 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026